These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26026863)

  • 21. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac magnetic resonance imaging findings predict major adverse events in apical hypertrophic cardiomyopathy.
    Hanneman K; Crean AM; Williams L; Moshonov H; James S; Jiménez-Juan L; Gruner C; Sparrow P; Rakowski H; Nguyen ET
    J Thorac Imaging; 2014 Nov; 29(6):331-9. PubMed ID: 25314027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy.
    Yamada T; Hirashiki A; Okumura T; Adachi S; Shimazu S; Shimizu S; Morimoto R; Takeshita K; Naganawa S; Kondo T; Murohara T
    J Card Fail; 2014 Nov; 20(11):825-32. PubMed ID: 25151210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis.
    Scott PA; Rosengarten JA; Curzen NP; Morgan JM
    Eur J Heart Fail; 2013 Sep; 15(9):1019-27. PubMed ID: 23558217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
    Appelbaum E; Maron BJ; Adabag S; Hauser TH; Lesser JR; Haas TS; Riley AB; Harrigan CJ; Delling FN; Udelson JE; Gibson CM; Manning WJ; Maron MS
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):78-85. PubMed ID: 22135401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
    Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
    Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M
    J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome.
    Babu-Narayan SV; Kilner PJ; Li W; Moon JC; Goktekin O; Davlouros PA; Khan M; Ho SY; Pennell DJ; Gatzoulis MA
    Circulation; 2006 Jan; 113(3):405-13. PubMed ID: 16432072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries.
    Babu-Narayan SV; Goktekin O; Moon JC; Broberg CS; Pantely GA; Pennell DJ; Gatzoulis MA; Kilner PJ
    Circulation; 2005 Apr; 111(16):2091-8. PubMed ID: 15851616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
    Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
    J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpectedly low left ventricular voltage on ECG in hypertrophic cardiomyopathy.
    Guerrier K; Madueme PC; Jefferies JL; Anderson JB; Spar DS; Knilans TK; Czosek RJ
    Heart; 2016 Feb; 102(4):292-7. PubMed ID: 26740481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Todiere G; Aquaro GD; Piaggi P; Formisano F; Barison A; Masci PG; Strata E; Bacigalupo L; Marzilli M; Pingitore A; Lombardi M
    J Am Coll Cardiol; 2012 Sep; 60(10):922-9. PubMed ID: 22935464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late gadolinium enhancement in Brugada syndrome: A marker for subtle underlying cardiomyopathy?
    Bastiaenen R; Cox AT; Castelletti S; Wijeyeratne YD; Colbeck N; Pakroo N; Ahmed H; Bunce N; Anderson L; Moon JC; Prasad S; Sharma S; Behr ER
    Heart Rhythm; 2017 Apr; 14(4):583-589. PubMed ID: 27919765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy.
    Doesch C; Dierks DM; Haghi D; Schimpf R; Kuschyk J; Suselbeck T; Schoenberg SO; Borggrefe M; Papavassiliu T
    Int J Cardiol; 2014 Dec; 177(2):429-35. PubMed ID: 25304065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing right ventricular deformation in hypertrophic cardiomyopathy patients with preserved right ventricular ejection fraction: a 3.0-T cardiovascular magnetic resonance study.
    Li X; Shi K; Yang ZG; Guo YK; Huang S; Xia CC; He S; Li ZL; Li C; He Y
    Sci Rep; 2020 Feb; 10(1):1967. PubMed ID: 32029853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
    Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
    Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.